DIFFERENCES IN AGE CHARACTERISTICS, TUMOR MACROSCOPIC SIZE AND HORMONE PROFILE BETWEEN CLASSIC PAPILLARY CARCINOMA PATIENTS AND FOLLICULAR VARIANTS IN Dr. KARIADI HOSPITAL, SEMARANG
DOI:
https://doi.org/10.36408/mhjcm.v8i2.508Keywords:
Classic Papillary Thyroid Carcinoma; Follicular Variant Papillary Thyroid Carcinoma; Age at diagnosis; Tumor macroscopic size; TSHs and fT4.Abstract
Background: New cases of Papillary Thyroid Carcinoma and Carcinoma patients at Dr. Kariadi Hospital, Semarang is quite high, where the most types are Classical Papillary Thyroid Carcinoma and Follicular Variant Papillary Thyroid Carcinoma. On the other hand, in diagnosing PTC, histopathological examination which is a gold standard sometimes has a subjective value. Therefore, it is necessary to have a correlation with the clinical characteristics of the patient in order to get a correct diagnosis. Aim: Understanding the differences in age characteristics, tumor macroscopic size and hormone profile between Classical Papillary Thyroid Carcinoma and Follicular Variant patients at Dr. Kariadi Hospital, Semarang. Method: Analytic observational research with cross sectional design. The number of samples was 38 medical records in which 18 cases of Classic Papillary Thyroid Carcinoma and 20 cases of Follicular Variant Papillary Thyroid Carcinoma. Data with a nominal scale, namely age were analyzed using the Fisher exact test, while the data with a numerical scale, namely the macroscopic size of the tumor and the hormone profile, were tested for normality of Saphiro Wilk then continued with the Mann-Whitney test. Result: Based on the Fisher exact test, there was significant difference (p = 0,009) between age characteristics and Classical Papillary Thyroid Carcinoma and Follicular Variant. In the Mann-Whitney test there was no significant difference (p = 0.3) between the macroscopic size of the classical papillary carcinoma and follicular variant and there was no significant difference TSHs (p = 0.501) and fT4 (p = 0.953) hormone profiles between Classic Papillary Thyroid Carcinoma and Follicular Variants. Conclusion: There was significant difference between the characteristics of age at diagnosis, and there was no significant difference between the macroscopic size of the tumor and the hormonal profile of Classical Papillary Carcinoma and Follicular Variants in Dr. Kariadi Hospital, Semarang.
Downloads
References
Putri E, Khambri D, Rusjdi SR. Hubungan Daerah Tempat Tinggal dengan Gambaran Histopatologi Karsinoma Tiroid pada Masyarakat Sumatera Barat. Jurnal Kesehatan Andalas [Internet]. 2017 [cited 2020 Feb 5]; 36(21):171–4. Available from : http://jurnal.fk.unand.ac.id
Chendrasari J, Rahmiati, Hamdani C. Gambaran Sitologi Aspirasi Tiroid pada Diagnosis Curiga Keganasan ( Karsinoma Papiler Tiroid ). Majalah Patologi Indonesia [Internet]. 2020 [cited 2020 Feb 5]; 29(1):1–7. Available from : https://majalahpatologiindonesia.com
Ridho MA, Qodir N, Triwani. Karakteristik Pasien Karsinoma Tiroid Papiler di Rumah Sakit Umum Pusat Dr . Mohammad Hoesin Periode Januari-Desember 2016. Majalah Kedokteran Sriwijaya, Th 50 [Internet]. 2018 [cited 2020 Feb 5]; 50(4):1-9. Available from : https://ejournal.unsri.ac.id
Crosby H, Pontoh V, Merung MA. Pola kelainan tiroid di RSUP Prof. Dr. R. D. Kandou Manado periode Januari 2013 - Desember 2015. Jurnal e-Clinic [Internet]. 2016 [cited 2020 Feb 5]; 4(1):1-8. Available from : https://ejournal.unsrat.ac.id
Fitriyani H. Hubungan Kadar Serum Tsh , T3 dan T4 dengan Tipe Histopatologi Karsinoma Tiroid di Departemen Patologi Anatomik Fakultas Kedokteran USU / RSUP H . Adam Malik Medan Tahun 2013-2015 [Internet]. 2016 [cited 2020 Feb 5]. Available from : http://repositori.usu.ac.id
American Thyroid Association. Thyroid Cancer (Papillary and Follicular). Am Thyroid Assoc [Internet]. 2016 [cited 2020 Feb 5]; 26(1):2-15. Available from: http://seer.cancer.gov/statfacts/html/thyro.html
Zaid L, Zuraidah E, Stephanie A. Peran Rearrangement RET / PTC pada Karsinoma Papiler Tiroid. Majalah Pratista Patologi [Internet]. 2019 [cited 2020 Feb 5]; 6(1):1-13. Available from : http://majalahpratistapatologi.com
Armerinayanti NIW. Ekspresi Matriks Metaloproteinase 9 pada Infiltrasi Karsinoma Tiroid Papiler Klasik dan Varian Folikuler. Departemen Patologi Anat Fakultas Kedokteran Universitas Udayana Denpasar [Internet]. 2015 [cited 2020 Feb 5]; 26(2):1-7. Available from: http://www.pps.unud.ac.id
Erickson LA. Atlas of Endocrine Pathology. American Journal of Clinical Pathology. Rochester,USA: Mayo Clinic College of Medicine; 1998.
Boelaert K. The association between serum TSH concentration and thyroid cancer. Endocrin Related Cancer [Internet]. 2009 [cited 2020 Feb 5]; 16(4):1065–72. Available from : https://pubmed.ncbi.nlm.nih.gov/19620248/
Lloyd R, Osamura R, Kloppel G, Rosai J. World Health Organization Classification of Tumours of Endocrine Organs. USA: WHO; 2017.
Haymart MR. Understanding the Relationship Between Age and Thyroid Cancer. Oncologist [Internet]. 2009 [cited 2020 Feb 25]; 14(3):216–21. Available from : https://pubmed.ncbi.nlm.nih.gov
Antika ID, Hanriko R, Larasati TA. Studi Diagnostik Ultrasonografi dalam Mendiagnosis Nodul Tiroid di RSUD Dr. H. Abdul Moeloek Bandar Lampung. Kedokteran Unila [Internet]. 2017 [cited 2020 Feb 5]; 8(2). Available from : http://juke.kedokteran.unila.ac.id/
Henke LE, Pfeifer JD, Baranski TJ, Dewees T, Grigsby PW. Long-term outcomes of follicular variant vs classic papillary thyroid carcinoma. Endocrine 50 Connections [Internet]. 2018 [cited 2020 Aug 5];7(12):1226–1235. Available from : https://www.ncbi.nlm.nih.gov/pmc/
Jeon EJ, Jeong YJ. Ultrasonographic Characteristics of the Follicular Variant Papillary Thyroid Cancer according to the Tumor Size. Journal of Korean Medical Science [Internet]. 2016 [cited 2020 Aug 5];31(3):397–402. Available from : https://www.ncbi.nlm.nih.gov/pmc/
Yang J, Gong Y, Yan S, Shi Q, Zhu J, Li Z, et al. Comparison of the clinicopathological behavior of the follicular variant of papillary thyroid carcinoma and classical papillary thyroid carcinoma: A systematic review and meta-analysis. Molecular and Clinical Oncology [Internet]. 2015 [cited 2020 Aug 7]; 3(4):753–64. Available from : https://www.ncbi.nlm.nih.gov/pmc/
Zarkesh M, Zadeh VA, Azizi F, Fanaei SA, Foroughi F, Hedayati M. The association of BRAF V600E mutation with tissue inhibitor of metalloproteinase3 expression and clinicopathological features in papillary thyroid cancer. Int J Endocrinol Metab [Internet]. 2018 [cited 2020 Aug 10];16(2):56. Available from : https://pubmed.ncbi.nlm.nih.gov
Franco AT, Malaguarnera R, Refetoff S, Liao XH, Lundsmith E, Kimura S, et al. Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice. Proc Natl Acad Sci USA [Internet]. 2015 [cited 2020 Aug 10]; 108(4):1615–20. Available from : https://pubmed.ncbi.nlm.nih.gov
Huang H, Rusiecki J, Zhao N, Chen Y, Ma S, Yu H, et al. Thyroid-Stimulating 51 Hormone, Thyroid Hormones and Risk of Papillary Thyroid Cancer: A Nested Case-Control Study [Internet]. 2019 [cited 2020 Aug 11]; 26(8):1–20. Available from : https://www.ncbi.nlm.nih.gov/pmc/
Additional Files
Published
How to Cite
Issue
Section
Citation Check
License
Copyright (c) 2021 Medica Hospitalia : Journal of Clinical Medicine
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyrights Notice
Copyrights:
Researchers publishing manuscrips at Medica Hospitalis: Journal of Clinical Medicine agree with regulations as follow:
Copyrights of each article belong to researchers, and it is likewise the patent rights
Researchers admit that Medica Hospitalia: Journal of Clinical Medicine has the right of first publication
Researchers may submit manuscripts separately, manage non exclusive distribution of published manuscripts into other versions (such as: being sent to researchers’ institutional repository, publication in the books, etc), admitting that manuscripts have been firstly published at Medica Hospitalia: Journal of Clinical Medicine
License:
Medica Hospitalia: Journal of Clinical Medicine is disseminated based on provisions of Creative Common Attribution-Share Alike 4.0 Internasional It allows individuals to duplicate and disseminate manuscripts in any formats, to alter, compose and make derivatives of manuscripts for any purpose. You are not allowed to use manuscripts for commercial purposes. You should properly acknowledge, reference links, and state that alterations have been made. You can do so in proper ways, but it does not hint that the licensors support you or your usage.